Astellas and Tottori University partner for oncolytic virus program

Astellas Pharma Inc. (Tokyo:4503) and Japan's Tottori University partnered to develop and commercialize an immunostimulating gene loading oncolytic virus to treat cancer. Astellas said the virus was ...